Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma
Clinical trial NCT05326308 · RECRUITING
Trial details
- NCT number
- NCT05326308
- Sponsor
- iOMEDICO AG
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-04-26
- Primary completion
- 2028-08-01
- Enrollment
- 705
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.